Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

5% minoxidil significantly increases hair follicle density.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

New technologies improve diagnosis and treatment of digestive disorders.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Hydrogels show promise in preventing and treating skin damage from radiation therapy.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Hirsutism worsens quality of life and mental health, and treatment with both medical help and therapy is most effective.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Chemotherapy can harm kidneys in breast cancer patients.

The apelinergic system might protect the heart from damage caused by doxorubicin.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Cetuximab can cause eyelash growth, which is rare but manageable.

A woman's hair turned white after taking a cancer drug called dasatinib.